O'Brien Patrick sold ARWR
January 4, 2024 · Form 4 insider transaction
O'Brien Patrick sold 1,600 shares of Arrowhead Pharmaceuticals, Inc. at $32.63 per share, a transaction worth $52.2K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
1,600
Price
$32.63
Total value
$52.2K
InsiderO'Brien Patrick
Role—
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateJanuary 4, 2024
Filing dateJanuary 5, 2024
Shares owned after402,226
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
Shares were sold pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.; Includes previously reported shares of common stock underlying Restricted Stock Units granted to the Reporting person which are subject to certain vesting conditions.